3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
2
Plasma cell
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
11
Colorectal Neoplasms
3
Prostatic Neoplasms
2
Neoplasms
2
Lung Neoplasms
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Patient Preference
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Lymphoma
1
Communication
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
pembrolizumab
3
Trastuzumab
3
Sunitinib
3
Magnetic Resonance Spectroscopy
3
selpercatinib
2
palbociclib
2
lenvatinib
2
larotrectinib
2
belinostat
2
Surveys and Questionnaires
2
Specimen Handling
2
Sirolimus
2
Nivolumab
2
Immunoglobulin G
2
Fluorodeoxyglucose F18
2
Disulfides
2
Biopsy
2
vandetanib
1
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
tislelizumab
1
tipifarnib
1
temsirolimus
1
spartalizumab
1
sapanisertib
1
romidepsin
1
relatlimab
1
regorafenib
1
pertuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thyroid Neoplasms
×
Focus Groups
×
Breast
×
Clear all
NCT06236373
2024-12-09
Survivorship
University of Modena and Reggio Emilia
Recruiting
45 enrolled